Referred to the House Committee on Energy and Commerce.
This resolution is a non-binding statement by the House expressing support for designating September 2026 as National Prostate Cancer Awareness Month and urging awareness, screening, research, and improved access to care. It does not create a law, change federal programs, or provide funding. If adopted, it records the House's official position and encourages citizens, groups, and providers to take action. It does not require action by the Senate or the President.
This House resolution expresses support for designating September 2026 as National Prostate Cancer Awareness Month.
It cites incidence, mortality, racial disparities, familial risk, and the value of early detection, and urges awareness, screening, research, and improved access to care.
The resolution also notes VA Precision Oncology Centers and calls on the public and organizations to observe the month with activities.
As a simple House resolution it is nonbinding and not a public law; likely to pass House but not become law.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the public-health topic and uses factual preambulatory language to justify designating a month for awareness; it relies on nonbinding exhortations rather than creating legal obligations or funding.
Screening emphasis: liberal and centrist want nuance; conservatives stress voluntariness
These are examples from the analysis, not a ranked list of the most-affected groups.
Screening emphasis: liberal and centrist want nuance; conservatives stress voluntariness
Likely supportive overall because the resolution highlights health disparities, research, and veteran services.
May press for stronger commitments on equitable access, insurance coverage, and inclusive outreach.
Will be attentive to screening harms and insist on informed consent and attention to marginalized groups.
Generally favorable as a nonbinding awareness resolution that supports research and veterans' care.
Will seek clarity on screening recommendations and costs, given PSA screening tradeoffs.
Views the measure as low-risk but limited in policy effect.
Likely supportive of an awareness resolution, especially its veteran focus and emphasis on early detection.
Prefers voluntary, private-sector led solutions and is cautious about federal mandates or increased spending.
Views the resolution as largely benign and symbolic.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a simple House resolution it is nonbinding and not a public law; likely to pass House but not become law.
The bill has not accumulated any surfaced votes yet.
Screening emphasis: liberal and centrist want nuance; conservatives stress voluntariness
As a simple House resolution it is nonbinding and not a public law; likely to pass House but not become law.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the public-health topic and uses factual preambulatory language to justify designating a month for…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.